Want to join the conversation?
$MDSO said it and Celltrion teamed up to transform global clinical trials for Biosimilars. Celltrion adopted $MDSO's cloud based technology to enhance clinical research programs for ailments including rheumatoid arthritis, respiratory diseases and cancer.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?